E. Istvan and J. Deisenhofer, Structural Mechanism for Statin Inhibition of HMG-CoA Reductase, Science, vol.292, issue.5519, pp.1160-1164, 2001.
DOI : 10.1126/science.1059344

A. Endo, The discovery and development of HMG-CoA reductase inhibitors, Atherosclerosis Supplements, vol.5, issue.3, pp.1569-1582, 1992.
DOI : 10.1016/j.atherosclerosissup.2004.08.026

M. Demierre, P. Higgins, S. Gruber, E. Hawk, and S. Lippman, Statins and cancer prevention, Nature Reviews Cancer, vol.62, issue.12, pp.930-942, 2005.
DOI : 10.1038/nrc1751

M. Katz, Therapy Insight: potential of statins for cancer chemoprevention and therapy, Nature Clinical Practice Oncology, vol.363, issue.2, pp.82-89, 2005.
DOI : 10.1038/ncponc0097

L. Bjerre and J. Lelorier, Do statins cause cancer? A meta-analysis of large randomized clinical trials, The American Journal of Medicine, vol.110, issue.9, pp.716-723, 2001.
DOI : 10.1016/S0002-9343(01)00705-7

R. Burkhardt, E. Kenny, J. Lowe, A. Birkeland, R. Josowitz et al., Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.11, pp.2078-2084, 2008.
DOI : 10.1161/ATVBAHA.108.172288

K. Hindler, C. Cleeland, E. Rivera, and C. Collard, The Role of Statins in Cancer Therapy, The Oncologist, vol.11, issue.3, pp.306-315, 2006.
DOI : 10.1634/theoncologist.11-3-306

M. Jakobisiak and J. Golab, Potential antitumor effects of statins (Review), International Journal of Oncology, vol.23, pp.1055-1069, 2003.
DOI : 10.3892/ijo.23.4.1055

G. Fritz and B. Kaina, Rho GTPases: promising cellular targets for novel anticancer drugs, Curr Cancer Drug Targets, vol.6, pp.1-14, 2006.

K. Satoh, T. Nakai, and K. Ichihara, Influence of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on mitochondrial respiration in rat liver during ischemia, European Journal of Pharmacology: Environmental Toxicology and Pharmacology, vol.270, issue.4, pp.365-369, 1994.
DOI : 10.1016/0926-6917(94)90014-0

E. Logette, L. Jossic-corcos, C. Masson, D. Solier, S. Sequeira-legrand et al., Caspase-2, a Novel Lipid Sensor under the Control of Sterol Regulatory Element Binding Protein 2, Molecular and Cellular Biology, vol.25, issue.21, pp.9621-9631, 2005.
DOI : 10.1128/MCB.25.21.9621-9631.2005

C. Laboisse, C. Augeron, M. Couturier-turpin, C. Gespach, A. Cheret et al., Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors, Cancer Res, vol.42, pp.1541-1548, 1982.

M. Bissery and G. Chabot, History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro, Bull Cancer, vol.78, pp.587-602, 1991.

M. Nejjari, W. Anderson, C. Pourreyron, M. Jacquier, J. Scoazec et al., The role of fibroblasts in the modulation of integrin-dependent interactions between the gastric cell line HGT-1 and fibronectin, International Journal of Cancer, vol.112, issue.4, pp.560-569, 2004.
DOI : 10.1002/ijc.20444

K. Livak and T. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, pp.402-408, 2001.

M. Hotz, J. Bosq, P. Zbaeren, J. Reed, G. Schwab et al., Spontaneous Apoptosis and the Expression of p53 and Bcl-2 Family Proteins in Locally Advanced Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.125, issue.4, pp.417-422, 1999.
DOI : 10.1001/archotol.125.4.417

A. Tsamandas, D. Kardamakis, P. Tsiamalos, A. Liava, V. Tzelepi et al., The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome, Anticancer Res, vol.29, pp.703-709, 2009.

M. Warr and G. Shore, Unique biology of Mcl-1: therapeutic opportunities in cancer, Curr Mol Med, vol.8, pp.138-147, 2008.

T. Megha, S. Lazzi, F. Ferrari, R. Vatti, C. Howard et al., Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics, Anticancer Res, vol.19, pp.163-169, 1999.

H. Kawamoto, H. Koizumi, and T. Uchikoshi, Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses

E. Kebebew, M. Peng, E. Reiff, Q. Duh, O. Clark et al., Diagnostic and Prognostic Value of Cell-cycle Regulatory Genes in Malignant Thyroid Neoplasms, World Journal of Surgery, vol.64, issue.7, pp.767-774, 2006.
DOI : 10.1007/s00268-005-0308-2

Y. Fukudome, K. Yanagihara, M. Takeichi, F. Ito, and S. Shibamoto, Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma, International Journal of Cancer, vol.28, issue.4, pp.579-583, 2000.
DOI : 10.1002/1097-0215(20001115)88:4<579::AID-IJC10>3.0.CO;2-U

M. Shah and D. Kelsen, Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease, J Natl Compr Canc Netw, vol.8, pp.437-447, 2010.

J. Klawitter, T. Shokati, V. Moll, and U. Christians, Effects of lovastatin on breast cancer cells: a proteo-metabonomic study, Breast Cancer Research, vol.32, issue.2, p.16, 2010.
DOI : 10.1007/s11745-997-0154-5